Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch & Lomb (BLCO) Cash & Equivalents (2021 - 2025)

Bausch & Lomb's Cash & Equivalents history spans 5 years, with the latest figure at $383.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 25.57% year-over-year to $383.0 million; the TTM value through Dec 2025 reached $383.0 million, up 25.57%, while the annual FY2025 figure was $383.0 million, 25.57% up from the prior year.
  • Cash & Equivalents reached $383.0 million in Q4 2025 per BLCO's latest filing, up from $310.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $437.0 million in Q2 2022 to a low of $174.0 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $309.0 million, with a median of $315.0 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 103.45% in 2022, then plummeted 35.87% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $174.0 million in 2021, then soared by 103.45% to $354.0 million in 2022, then decreased by 6.5% to $331.0 million in 2023, then dropped by 7.85% to $305.0 million in 2024, then grew by 25.57% to $383.0 million in 2025.
  • Per Business Quant, the three most recent readings for BLCO's Cash & Equivalents are $383.0 million (Q4 2025), $310.0 million (Q3 2025), and $266.0 million (Q2 2025).